Oncotelic Therapeutics Inc financial statements
Oncotelic Therapeutics Inc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | USD 249.3M | 10-Q |
| Cash and equivalents | USD 88.86K | 10-Q |
Oncotelic Therapeutics Inc financials on 6ix · Oncotelic Therapeutics Inc on 6ix